Related Experiment Video
Updated: Aug 9, 2026

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
Published on: October 16, 2013
Down-regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG
U G Andersson1, L Björk, U Skansén-Saphir
1Department of Immunology, Arrheniuslaboratories for Natural Sciences, Stockholm University, Sweden.
Insights
Pooled human immunoglobulin (i.v.Ig) inhibits T-cell proliferation and cytokine production, demonstrating immunomodulatory effects. This study reveals how i.v.Ig impacts immune responses at the single-cell level.
Area of Science:
- Immunology
- Cell Biology
Background:
- Intravenous immunoglobulin (i.v.Ig) is used for various immune conditions.
- Its precise immunomodulatory mechanisms, especially on cytokine production, require further elucidation.
Purpose of the Study:
- To investigate the effects of i.v.Ig on in vitro cytokine production and T-cell activation.
- To analyze these effects at the single-cell level using specific assays.
Main Methods:
- Mononuclear cells from healthy donors were cultured and stimulated using anti-CD3 monoclonal antibody (mAb) or phorbol 12-myristate 13-acetate (PMA) with ionomycin.
- Cells were treated with or without i.v.Ig for 96 hours.
- Cytokine production and interleukin-2 receptor (IL-2R) expression were measured using cytokine-specific mAb and indirect immunofluorescence.
Main Results:
- i.v.Ig significantly inhibited T-cell proliferation and blast transformation.
- Production of T-cell lymphokines (IL-2, IL-10, IFN-gamma, TNF-beta) was downregulated by i.v.Ig with anti-CD3 stimulation.
- Effects on cytokine production varied with stimulation method and time, with some cytokines (IL-8, TNF-alpha, IFN-gamma) showing less or no suppression.
- IL-2R expression was suppressed in anti-CD3 stimulated cells but not in PMA/ionomycin-stimulated cells.
Conclusions:
- Pooled IgG exhibits immunomodulatory activity by directly affecting cytokine production and T-cell proliferation.
- The findings suggest i.v.Ig's therapeutic potential may stem from these direct cellular and molecular impacts.
Abstract:
The influence of pooled human IgG preparations for intravenous use (i.v.Ig) on in vitro-induced cytokine production was studied at the single-cell level using cytokine-specific monoclonal antibodies (mAb) and indirect immunofluorescent technique. Cultured mononuclear cells from peripheral blood from healthy adult donors were polyclonally stimulated for 96 hr by either direct ligation of T-cell receptors using immobilized anti-CD3 mAb or by a combination of a protein kinase C activator [phorbol 12-myristate 13-acetate (PMA)] and a calcium ionophore (ionomycin) in the absence or presence of i.v.Ig. A marked inhibition of proliferation and blast transformation was noted in all i.v.Ig exposed cultures, despite good cell survival. The production of the T-cell lymphokines interleukin-2 (IL-2), IL-10,interferon-gamma (IFN-gamma) and tumour necrosis factor-beta (TNF-beta) was significantly down-regulated during the whole studied period in the i.v.Ig containing anti-CD3 stimulated cultures. The synthesis of the monokine IL-8 was not suppressed and that of TNF-alpha, which was made by both lymphocytes and monocytes, was only moderately inhibited. Somewhat different and more transient effects were observed in the i.v.Ig-exposed PMA/ionomycin-activated cultures. The production of IL-2, IL-3, IL-4, IL-5, IL-10, TNF-beta and granulocyte-macrophage colony-stimulating factor (GM-CSF) was down-regulated during the initial phase of the cultures up to 48 hr, but not at 48-96 hr. The synthesis of IFN-gamma and TNF-alpha was unaffected of the influence of i.v.Ig during the entire culture period. The expression of IL-2 receptors (IL-2R) was significantly suppressed in the i.v.Ig-treated anti-CD3-activated cells, but not in the PMA/ionomycin-stimulated cultures. Taken together our results indicate that pooled IgG may mediate immunomodulation by direct effects on cytokine production and on T-cell proliferation.

